Affordable Access

Publisher Website

Development of a symptomatic intracranial meningioma in a male-to-female transsexual after initiation of hormone therapy

Authors
Publisher
Elsevier Ltd
Publication Date
Volume
17
Issue
10
Identifiers
DOI: 10.1016/j.jocn.2010.01.036
Keywords
  • Meningioma
  • Sex Hormone
  • Transsexual
Disciplines
  • Medicine

Abstract

Abstract Transsexual patients are routinely treated with sex hormone therapy, which may be a risk factor for meningiomas, although the data are largely inconclusive. Here we describe a male-to-female transsexual patient treated with estradiol patches, who developed an occipital meningioma causing generalized seizures. This is the second report of a male-to-female transsexual patient who developed a symptomatic meningioma after sex hormone treatment, adding to the growing evidence that sex hormones contribute to the pathogenesis of meningiomas. Meningiomas may therefore complicate hormone therapy and sex hormones may be contraindicated in transsexual candidates with meningiomas identified upon screening.

There are no comments yet on this publication. Be the first to share your thoughts.